HAWTHORNE, N.Y.--(BUSINESS WIRE)--May. 11, 2012--
Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that
its Annual Report for the fiscal year ended December 31, 2011 on Form
20-F, filed with the Securities and Exchange Commission (the “SEC”) on
April 5, 2012, is available within the Investor Relations section of
Taro’s website at www.taro.com.
Hard copies of the report may be ordered free of charge by sending
requests to Taro Pharmaceuticals U.S.A., Inc., 3 Skyline Drive,
Hawthorne, NY 10532, attention: William J. Coote or via email to William.Coote@Taro.com.
Additionally, the report may be accessed on the SEC’s website at www.sec.gov.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based
pharmaceutical company, dedicated to meeting the needs of its customers
through the discovery, development, manufacturing and marketing of the
highest quality healthcare products. For further information on Taro
Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.
Source: Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd.
William J. Coote, VP,